ライフサイエンスコーパス: uncertain

1 behind this directed movement have remained uncertain.

2 ct of transcatheter valve durability remains uncertain.

3 s of global atmospheric Se fluxes are highly uncertain.

4 with recent acute coronary syndrome remains uncertain.

5 ons, but the safety of long-term use remains uncertain.

6 rders, including PAMI syndrome, has remained uncertain.

7 wth, but the relevance of vitamin B6 remains uncertain.

8 ary progressive multiple sclerosis (PPMS) is uncertain.

9 upt mitochondrial cristae, however, has been uncertain.

10 sia (CIN); however, causal inference remains uncertain.

11 iving patterns of vegetative greening remain uncertain.

12 traps, which may render species persistence uncertain.

13 nsity; yet projections of both remain highly uncertain.

14 therapy (ART), the of baseline genotypes is uncertain.

15 and because its relationship to outcomes is uncertain.

16 However, their relative utility is uncertain.

17 cal processes and are therapeutic targets is uncertain.

18 and soil carbon iCO(2) responses are highly uncertain.

19 ulations and to longer-term survival remains uncertain.

20 l temperature and water availability remains uncertain.

21 for some modalities, long-term durability is uncertain.

22 (AMVP) form remains incompletely defined and uncertain.

23 tween the two therapeutic approaches remains uncertain.

24 rall cost-effectiveness of screening remains uncertain.

25 al anticoagulation (OAC) in ESRD patients is uncertain.

26 ry, lifetime, and surface deposition remains uncertain.

27 lar assist devices and cardiac transplant is uncertain.

28 ondition rendered internal-model predictions uncertain.

29 ssociated with ACR, but their causal role is uncertain.

30 nticoagulation strategy in these patients is uncertain.

31 tent influence cardiovascular health remains uncertain.

32 70; 95% CI 0.18-2.74), but these results are uncertain.

33 nic transient complement activation, remains uncertain.

34 , population-wide distributions of BC remain uncertain.

35 anagement of isolated nocturnal hypoxemia is uncertain.

36 en shoulder, but their effectiveness remains uncertain.

37 sult, the utility of this phenomenon remains uncertain.

38 nd safety of rivaroxaban in this context are uncertain.

39 -related death following adenoma removal are uncertain.

40 bservational associations are causal remains uncertain.

41 going and future disturbance is increasingly uncertain.

42 Whether these effects occur in infants is uncertain.

43 sk of cerebrovascular accident (CVA) remains uncertain.

44 d, their physical mechanisms are still quite uncertain.

45 nder future warming, however, remains highly uncertain.

46 omes- particularly in younger adults-remains uncertain.

47 settings, but applicability to SARS-CoV-2 is uncertain.

48 t the underlying molecular mechanism remains uncertain.

49 are beneficial in COVID-19 treatment remains uncertain.

50 ntervention with drug-eluting stents remains uncertain.

51 cell output to physiological control remains uncertain.

52 t positives, and optimal testing strategy is uncertain.

53 ding T globally, while the magnitudes remain uncertain.

54 ostatic hyperplasia (BPH) and prostatitis is uncertain.

55 the oceans, although the net impacts remain uncertain.

56 wever, whether the relationship is causal is uncertain.

57 isease, but its clinical consequences remain uncertain.

58 when costs for new edges are small or inputs uncertain.

59 ave more-extensive HIV-1 drug resistance are uncertain.

60 t summer precipitation changes remain highly uncertain.

61 ng-term effectiveness of the intervention is uncertain.

62 the economic case for widespread use remains uncertain.

63 stances that facilitate domestication remain uncertain.

64 nction differ between these two therapies is uncertain.

65 or favouring the autoimmune process is still uncertain.

66 imum treatment for this CSC variant is still uncertain.

67 onal or country-wide scales therefore remain uncertain.

68 he magnitude of these changes remains highly uncertain.

69 coaching skills among practicing surgeons is uncertain.

70 when internal-model predictions are rendered uncertain.

71 dverse RV remodeling in COVID-19 patients is uncertain.

72 ctrum disorder (ASD), its brain bases remain uncertain.

73 prophylactic hemoclipping on delayed PPB is uncertain.

74 d function at the plant scale, remain highly uncertain.

75 of how uncoupled forks are restarted remain uncertain.

76 t processes at stake in such context are yet uncertain.

77 cardiac structure and function in HFrEF are uncertain.

78 in young children, the pathobiology remains uncertain.

79 ith different genetic susceptibility remains uncertain.

80 ivity in the process of CO formation remains uncertain.

81 s underlying these pathogenic effects remain uncertain.

82 sitivity to external climate forcing remains uncertain.

83 d, the physics behind its formation is still uncertain.

84 ication and arterial stiffness in CKD remain uncertain.

85 models for coronary artery disease (CAD) is uncertain.

86 Status of the flap after surgery often is uncertain.

87 ions, whose existence and prevalence remains uncertain.

88 in through a BMP2-dependent mechanism remain uncertain.

89 atic secondary immunodeficiency (SID) remain uncertain.

90 estimate of within-sample (alpha) diversity uncertain.

91 most appropriate follow-up strategy remains uncertain.

92 tensively investigated, loss pathways remain uncertain.

93 tion and a bioprosthetic mitral valve remain uncertain.

94 lication but the molecular mechanism remains uncertain.

95 l brain morphometry in schizophrenia remains uncertain.

96 isk reduction of perinatal mortality remains uncertain.

97 carbon fixation allocated belowground remain uncertain.

98 adiation, yet benefits, harms, and costs are uncertain.

99 nce individual-level food insecurity remains uncertain.

100 etiology of acute scrotal pain (ASP) remains uncertain.

101 The effects on other outcomes were uncertain.

102 rising change or existing beliefs are highly uncertain.

103 arth's plate tectonic cooling system remains uncertain.

104 n pathways, but their mode of egress remains uncertain.

105 es, leaving the specific target of actinonin uncertain.

106 characteristics of such an effort have been uncertain.

107 condary prevention of complications is still uncertain.

108 er space, time, and stakeholder group remain uncertain.

109 re, inducing population (herd) protection is uncertain.

110 and risk of venous thromboembolism (VTE) is uncertain.

111 pulmonary disease (COPD) and hypercapnia is uncertain.

112 ional benefits to physical function, remains uncertain.

113 -15 and venous thromboembolism (VTE) remains uncertain.

114 n (CrAg) by lateral flow assay is frequently uncertain.

115 's clearance of tubular secretory solutes is uncertain.

116 icting renal and patient outcomes in LCCN is uncertain.

117 models, but whether it is beneficial remains uncertain.

118 ion of human immunodeficiency virus (HIV) is uncertain.

119 f the three C-terminal domains of OPG remain uncertain.

120 agnosis when the presence of parkinsonism is uncertain.

121 clinical Alzheimer-type dementia (CATD) are uncertain.

122 ional diversity of the AAA+ superfamily were uncertain.

123 The role of psychological therapies is uncertain.

124 erm cost-effectiveness and budget impact are uncertain.

125 ime, but the influence of forest age remains uncertain.

126 atients with obesity and hypertension remain uncertain.

127 baseline characteristics and timing remains uncertain.

128 arker accuracy for Alzheimer disease (AD) is uncertain.

129 clinical Alzheimer-type dementia (CATD) are uncertain.

130 ed in the face of altered resource inputs is uncertain.

131 genitors other than basal-like cells remains uncertain.

132 tanding of virus transmission, which remains uncertain.

133 m continued survival of right whales remains uncertain.

134 the mechanisms by which bnAbs emerge remain uncertain.

135 evidence for dupilumab-related serious AE is uncertain.

136 al for this strategy to achieve cure remains uncertain.

137 levels of adherence to social distancing is uncertain.

138 tion and subsequent roles in cancer risk are uncertain.

139 t their relative number and effect have been uncertain.

140 tion; however, the processes involved remain uncertain.

141 t the cause in the majority of cases remains uncertain.

142 ibutes to the development of hypertension is uncertain.

143 e cost-effectiveness of adding 5FC to FLU is uncertain.

144 ther that contributes to repeat expansion is uncertain.

145 in motor neuron disease pathogenesis remains uncertain.

146 n those who receive medical therapy alone is uncertain.

147 s death and other cardiovascular outcomes is uncertain.

148 Isoprene emissions are highly uncertain(1,9), as is the nonlinear chemistry coupling i

149 evere traumatic brain injury but has been of uncertain aetiology.

150 However, current estimates are still uncertain and do not account for diel variability of CH(

151 Uncertain and dynamic environments may require neural ha

152 e their foraging behaviors in the context of uncertain and dynamic resource availability, and provide

153 he generalizability of the study findings is uncertain and requires further research.

154 and anxiety disorders, but responsiveness is uncertain and side effects often lead to discontinuation

155 children, adolescents, and young adults are uncertain and that the evidence is insufficient to asses

156 ivity of productivity to surface buoyancy is uncertain and the relative importance of the physical dr

157 a median value of 3.5 to 6.9 was considered uncertain, and a median value of 7.0 to 9.0 was consider

158 Our estimates are uncertain, and focus on underlying conditions rather tha

159 Hexon:VI stoichiometry has been uncertain, and only fragments of VI have been identified

160 unicipal water treatment plants is currently uncertain, and the mechanisms involved in microplastic (

161 ere inconsistently defined, and methods with uncertain applicability to typical clinical settings wer

162 In methodologically heterogeneous studies of uncertain applicability to typical clinical settings, am

163 Its taxonomic affinity is uncertain as it has a picornavirus-like cassette of enzy

164 Trust decisions are inherently uncertain, as people usually have incomplete information

165 ith stable ischemic heart disease (SIHD) are uncertain, as prior studies have been based on selected

166 K antagonist oral anticoagulants (NOACs) is uncertain, as they have not been compared directly in ra

167 angdong, although phylogenetic clustering is uncertain because of low virus genetic variation early i

168 f serious adverse events with bevacizumab is uncertain because of the lack of specificity to conditio

169 However, underlying mechanisms remain uncertain because the partial contributions of the chall

170 vations of BC is hindering the evaluation of uncertain bottom-up emission inventories (EIs) and there

171 However, due to complex and uncertain brain connectivity features in the cognitive d

172 ier signal whose mechanism of action remains uncertain but does not involve an amino acid change in F

173 Nurses were uncertain but enthusiastic about educational and technol

174 The cause of this injury is uncertain but is suspected to be related to myocarditis,

175 The mechanism of PS exposure remains uncertain but it can follow increased intracellular Ca(2

176 arctica will contribute to sea level remains uncertain, but multimeter sea level rise is likely for a

177 activity while human participants engage in uncertain choices for prospective physical effort, befor

178 Cancer drugs with low or uncertain clinical benefit might be prioritised for pric

179 ed more procedural myocardial infarctions of uncertain clinical importance.

180 line, but differences versus placebo were of uncertain clinical importance.

181 Intervention benefits were small and of uncertain clinical importance.

182 other non-vaccine-matched antigens, and the uncertain clinical significance of the observed immunolo

183 of ET, with additional neurological signs of uncertain clinical significance.

184 Limitations comprise the uncertain contribution of risk factors, comorbidities, a

185 ns, but these measurements rely on large and uncertain corrections and are insensitive to most of the

186 nating polyneuropathy (CIDP) and diabetes is uncertain despite important diagnostic and management im

187 and magnitude of this feedback remain highly uncertain due largely to our limited understanding of th

188 tes produced by these methods are inherently uncertain due to the impossibility of actually tracing e

189 pact of iodine in the stratosphere is highly uncertain due to the lack of previous quantitative measu

190 by individuals that are habituated to noisy, uncertain environments where private information about t

191 When learning about dynamic and uncertain environments, people should update their belie

192 onfounding materials whose properties remain uncertain, even after years of study.

193 important bias in estimating probability of uncertain events, describes humans' tendency to underwei

194 meaningfully express their confidence about uncertain events.

195 Although the mechanisms driving BPD remain uncertain, exposure to hyperoxia is thought to contribut

196 MRI resulted in eight of 17 cases (47%) with uncertain findings.

197 Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, proph

198 ation from out-of-hospital cardiac arrest is uncertain for patients without ST-segment elevation.

199 considering partially specified models with uncertain functions, but this goes beyond well-establish

200 s who decline a DCD50 offer must wait for an uncertain future offer.

201 ve individual growth, and (4) living with an uncertain future.

202 Given uncertain genotypes with individualized probabilities, S

203 Population growth and the uncertain hazards that accompany climate change have put

204 ree defences, and insect outbreaks are still uncertain, hindering our ability to accurately predict t

205 However, it remains uncertain how drought resistance and resilience of fores

206 It remains uncertain how the global processes of WPE and climate ch

207 However, it remains uncertain how to best utilize these strategies in the co

208 It remains uncertain, however, how it relates to amyloid and tau pa

209 It is uncertain if food antigen processing and immune activati

210 onic-vibrational mixing, however, it remains uncertain if such mixing significantly influences energy

211 It is uncertain if the incidence of cirrhosis has previously b

212 It is uncertain if the risk of aortic dilation of varying degr

213 It is uncertain if this observed association arises through pr

214 However, it remains uncertain if ZIKV infection in pregnancy also increases

215 unity among immunocompetent individuals with uncertain immune or vaccination status.

216 o shorten LOS under financial pressures with uncertain impact on patient outcomes.

217 tude of stressors that likely co-occur, with uncertain impacts.

218 f primary versus secondary sources, has been uncertain in part because of limited knowledge of the pr

219 roups of autonomous individuals to transform uncertain information into unified decisions which are p

220 s inherited X-linked recessive, and 1 was of uncertain inheritance.

221 ation to update beliefs derived from weak or uncertain initial evidence.

222 ed laboratory experiments to account for the uncertain input data and the lack of uptake/depuration r

223 and independent or newly emerging clones of uncertain leukemogenic potential.

224 , 144 (56.5%) non-lobar ICH and 2 (0.8%) had uncertain location.

225 s found to induce heightened responsivity to uncertain, low-imminence threat while blunting cardiovas

226 bon sink in response to iCO(2) , albeit with uncertain magnitude and strong suggestion of a role for

227 ude their rare and unpredictable occurrence, uncertain mechanisms of solid-state assembly, and low th

228 we find that abandoned wells remain the most uncertain methane source in the U.S. and become the most

229 hile the mechanistic etiology of JBS remains uncertain, mutation of both Ubr1 and Ubr2 in the mouse o

230 Our experimental results settle the most uncertain nuclear physics input to BBN calculations and

231 ted States (23.6%); however, the etiology is uncertain.Objectives: In this study, we sought to uncove

232 ct of discharge delay on patient outcomes is uncertain.Objectives: To investigate the association bet

233 Despite this, the uncertain origin of association signals will likely comp

234 synaptic and postsynaptic spiking are highly uncertain, our results are partially consistent with pre

235 change is impacting fisheries worldwide with uncertain outcomes for food and nutritional security.

236 ent of recurrent wheezing and asthma remains uncertain, particularly in the high-risk group of infant

237 ning of MRD in multiple myeloma (MM) remains uncertain, particularly when assessed by next-generation

238 There are uncertain patterns of demand, and transfusion institutio

239 xplorative and directed towards subjectively uncertain predictors (positive uncertainty effect).

240 curate predictors increased over time, while uncertain predictors were avoided (negative uncertainty

241 d a deteriorated quality of life (QOL), with uncertain prognosis and limited treatment options.

242 In this study, subjects chose between uncertain prospects where estimating reward probability

243 t its outcomes and cost-effectiveness remain uncertain.PurposeTo determine if biennial DBT is cost-ef

244 This will continue in the future but at an uncertain rate and observational estimates are limited t

245 which we confirmed as mistakes, and two with uncertain relationships.

246 the location and timing of odor packets are uncertain, remains unclear.

247 The uncertain response of marine terminating outlet glaciers

248 and have been proposed to have distinct, if uncertain, roles in protein and amino acid utilization.

249 orcement-based learning with accumulation of uncertain sensory evidence.

250 18%, P<0.0001) but an excess of variants of uncertain significance (24%, P<0.0001), as compared to W

251 ed as benign (n=1702), likely benign (n=33), uncertain significance (n=71), likely pathogenic (likely

252 can further reduce the burden of variants of uncertain significance (VUS).

253 of a large set of PALB2 missense variants of uncertain significance (VUSs).

254 least one individual to date are variants of uncertain significance (VUSs).

255 e patients (6%) with minute T-cell clones of uncertain significance accounting for 53-136 cells/mul.

256 A monoallelic variant of uncertain significance affecting a lymphocyte cytotoxici

257 Since C241T is in the 5' UTR with uncertain significance and the characteristics can be ca

258 n with bacterial sepsis detected variants of uncertain significance in PID genes in 1 out of 5 childr

259 ed missense variants are deemed "variants of uncertain significance" (VUS).

260 ts tested but one, which was reclassified to uncertain significance, led to a loss-of-function of SK2

261 xacerbate complex issues such as variants of uncertain significance, secondary findings and the poten

262 e the likelihood of identifying a variant of uncertain significance, which is resolved only rarely by

263 d LS, and 11 more (2.2%) had MMR variants of uncertain significance.

264 ing should not be made based on a variant of uncertain significance.

265 ikely pathogenic variants and 21 variants of uncertain significance.

266 d thus TNNI3:p.R79C is considered variant of uncertain significance.

267 of which are currently listed as variants of uncertain significance.

268 likely pathogenic variants and 2 variants of uncertain significance.

269 by impulse oscillometry, this finding was of uncertain significance.

270 ikely pathogenic: 31%, excess of variants of uncertain significance: 7%).

271 thane source in the U.S. and become the most uncertain source in Canada.

272 ndoned oil and gas wells are one of the most uncertain sources of methane emissions into the atmosphe

273 ts of population-based screening for CKD are uncertain; that there is potential for harms; that scree

274 While the durability of the effect is uncertain, this trial provides evidence that a low-cost

275 type: high responsivity to anxiety-provoking uncertain threat and responsivity to certain conditioned

276 pecifically impaired rapid discrimination of uncertain threat and safety.

277 omponent of scaling: rapid discrimination of uncertain threat and safety.

278 d a specific role in rapid discrimination of uncertain threat and safety.SIGNIFICANCE STATEMENT Rapid

279 oidosis (ATTR) (N = 1, 3.3%), and amyloid of uncertain type (N = 1, 3.3%).

280 ance deviation is allowed) regardless of the uncertain upstream conditions.

281 mergence of drug-resistant viral strains and uncertain vaccine prospects highlight the pressing need

282 rbs solar radiation, leading to a strong but uncertain warming effect on climate.

283 However, it was uncertain what such activation reflected.

284 It is uncertain what the best strategy is for offering populat

285 Nevertheless, this remains uncertain when receiving a kidney from a donor >=80 year

286 However, it remains uncertain where the initial alpha-synuclein aggregates o

287 paracellular HCO(3) (-) flux, and it remains uncertain whether an acidic pH produced by loss of cysti

288 It is uncertain whether depressive symptoms are independently

289 It is uncertain whether invasive ventilation can use lower pos

290 It is uncertain whether or not low to moderate glucocorticoid

291 It remains uncertain whether prototypical facial features in emotio

292 However, it remains uncertain whether recovered organic residues represent o

293 It has remained uncertain whether the mechanisms of visual perceptual le

294 h performed outside the United States, it is uncertain whether these findings also reflect the US exp

295 It is uncertain whether this risk has changed in the era of wi

296 Furthermore, it remains uncertain which joint cells and SASP-factors contribute

297 It is still uncertain which viruses (besides enteroviruses) cause di

298 eness of its use in patients with PSC remain uncertain, with only a few studies performed on this sma

299 In an uncertain world, the ability to predict and update the r

300 aking, and learning to help us survive in an uncertain world.